Data / Form D filings / CancerGuide Diagnostics, Inc.
CancerGuide Diagnostics, Inc.: Form D filings
CancerGuide Diagnostics, Inc., a biotechnology company in Durham, NC, filed 2 Form D notices with the SEC in 2010. The latest, on March 25, 2010, reports $2.7 million sold of a $10.5 million offering to 5 investors.
Find out what CancerGuide Diagnostics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4307 EMPEROR BOULEVARD, YORKSHIRE PLACE, SUITE 200, Durham, NC, 27703
- Phone
- (919) 474-2439
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2006
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1481448
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 25, 2010 | Amendment | $10,499,998 | $2,749,999 | $7,749,999 | 5 | Jan 20, 2010 | sec.gov |
| Jan 26, 2010 | New notice | $10,499,998 | $2,000,000 | $8,499,998 | 5 | Jan 20, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David King | Director | |
| William Haas | Executive Officer | |
| Garheng Kong | Director | |
| Myla Lai-Goldman | Executive Officer, Director | |
| Judd Staples | Executive Officer | |
| Clay Thorp | Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Mar 22, 2010 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CancerGuide Diagnostics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.